NCT01445288 2026-04-14
Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors
National Institutes of Health Clinical Center (CC)
Completed
Clinical Trials
15 trialsNCT07173166 2026-03-10
CARE-T
Instituto de Investigacion Sanitaria INCLIVA
Phase NA Recruiting
NCT01949662 2026-02-13
Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer
M.D. Anderson Cancer Center
Phase 2 Active not recruiting
NCT07403812 2026-02-11
Assessing DCog Short for Neurotoxicity in CAR-T
Beth Israel Deaconess Medical Center
Phase NA Not yet recruiting
NCT07357636 2026-01-28
Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors
Shantou University Medical College
Recruiting
NCT07333976 2026-01-12
o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer
Tri-Service General Hospital
Phase 2 Completed
NCT04514029 2026-01-08
Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel
Masonic Cancer Center, University of Minnesota
Phase EARLY_PHASE1 Active not recruiting
NCT07320950 2026-01-06
Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients
Sun Yat-sen University
Phase 3 Completed
NCT03696784 2025-12-08
Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma
UNC Lineberger Comprehensive Cancer Center
Phase 1 Active not recruiting
NCT05025826 2025-12-02
PROPERTY
Nantes University Hospital
Phase NA Active not recruiting
NCT04150913 2025-11-25
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
Massachusetts General Hospital
Phase 2 Completed
NCT00727922 2025-11-20
MnDPDP-K04
Assistance Publique - Hôpitaux de Paris
Phase 2 Completed
NCT04583124 2025-11-18
ATENTO
Universidad de Granada
Phase NA Completed
NCT00978458 2025-09-08
Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma
Eastern Cooperative Oncology Group
Phase 3 Active not recruiting
NCT06950190 2025-08-12
(ECCPC)
Ellis Medicine
Phase 3 Enrolling by invitation